Zhongsheng Tong

机构：Tianjin Medical University Cancer Institute and Hospital · ORCID：0000-0002-6495-3981

发表论文 67 篇 · 总被引 971 次 · h-index 14

代表论文

• Landscape of somatic alterations in large-scale solid tumors from an Asian population (2022 · Nature Communications · 被引 128)
• Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer (2022 · Clinical and Translational Medicine · 被引 52)
• Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human (2021 · Frontiers in Cell and Developmental Biology · 被引 37)
• Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer (2022 · MedComm · 被引 31)
• Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial (2025 · Nature Communications · 被引 11)
• Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer: a long-term safety and overall survival update from the randomised, double-blind, placebo-controlled, phase 3 trial (2023 · Translational Breast Cancer Research · 被引 8)